Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSCC_ASC in Ischemic Heart Disease and Heart Failure
NCT03092284Phase 2Completed
- Sponsor
- Cell2Cure
- Start
- Sep 2015
- Primary completion
- Jul 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CSCC_ASC in ischemic heart disease (IHD), heart failure (HF), sponsored by Cell2Cure. Started Sep 2015; status: completed.
02
Drugs
CSCC_ASC
03
Conditions
ischemic heart disease (IHD)heart failure (HF)
Beyond the preview
Go deeper on NCT03092284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092284.